Designing Transfer Carts for Class 100 Conditions

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-08-02-2003
Volume 27
Issue 8

FDA has found several pharmaceutical companies not maintaining Class 100 conditions within transfer carts. The author discusses an approach for designing a transfer cart that will satisfy such conditions.

External Link - article-66514.pdf

Articles in this issue
BIO Update
Designing Transfer Carts for Class 100 Conditions
An Update on Osmotic Drug Delivery
The Influence of Pregelatinized Starch Disintegrants on Interacting Variables that Act on Disintegrant Properties
New FDA Initiatives Aim to Spur Innovation
Interphex Serves as a Showcase for New Materials and Machines
August 2003
In the Spotlight August 2003
Recent Videos
Industry Outlook 2025: European Political Impacts on the Supply Chain
Industry Outlook 2025: European Political Impacts on the Supply Chain
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
AAPS National Biotechnology Conference 2025: High-Concentration Biologics
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
Industry Outlook 2025: The Future of Technology in the Biopharma Industry
AAPS National Biotechnology Conference 2025: AAV Vector Production
AAPS National Biotechnology Conference 2025: AAV Vector Production
Gaylord Chemical is Now gChem
Gaylord Chemical is Now gChem
BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
BioDuro is Redefining CRDMO Partnerships With End-to-End Innovation
Industry Outlook 2025: European Geopolitical Impact on Pharma
Industry Outlook 2025: European Geopolitical Impact on Pharma
Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
Behind the Headlines Episode 16: NIH Funding, Re-Shoring, Tariffs, and Cell and Gene Therapies
Industry Outlook 2025: Political Implications for Pharma
Industry Outlook 2025: Political Implications for Pharma
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Drug Digest: Keeping Pace with Progressive Technologies in Biopharma Development
Related Content
Darmstadt, Germany - November 10, 2021: A building at the headquarters of science and technology company Merck KGaA. | Image Credit: © Anne Czichos - stock.adobe.com

Merck KGaA Becomes Strategic Partner in Peregrine Ventures’ Incentive Incubator

Patrick Lavery
May 15th 2025
Article

Merck will have early-stage opportunities to help startups set up for future success in the pharmaceutical and life sciences fields.

Site Logo

Transformations in Drug Development for Cell and Gene Therapies

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Pharmacy, hands and prescription medicine for customer with paper bag for healthcare, drugs and pharmaceutical. Closeup of a pharmacist or medical worker with person in drugstore for retail service | Image Credit: © Azee Jacobs/peopleimages.com - stock.adobe.com

Trump Issues Executive Order Aimed at Reducing Prescription Drug Prices for US Patients

Patrick Lavery
May 13th 2025
Article

According to the White House, the order builds on actions taken in the president’s first term to reduce price disparities domestically.

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang

PPD;Thermo Fisher Scientific
March 28th 2025
Podcast

As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.

Site Logo

Improve Your Efficiency in Production

Fedegari
May 13th 2025
Article

Example of how we offer creative and interesting solutions to our customers to improve efficiency in production.

Site Logo

Be Proactive Not Reactive

Fedegari
May 13th 2025
Article

We want to inform our customers that we have an excellent tech center available to assist them to develop together tailor-made solutions and personalized technologies, solve problems and complete hands-on training on our machines.